市場調查報告書

耳鼻喉科 (ENT) 用設備的全球市場 :各產品、終端用戶、地區的成長率,趨勢及預測(2018年∼2023年)

ENT Devices Market - Growth, Trends, and Forecasts (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 390827
出版日期 內容資訊 英文 115 Pages
商品交期: 2-3個工作天內
價格
耳鼻喉科 (ENT) 用設備的全球市場 :各產品、終端用戶、地區的成長率,趨勢及預測(2018年∼2023年) ENT Devices Market - Growth, Trends, and Forecasts (2020 - 2025)
出版日期: 2020年06月01日內容資訊: 英文 115 Pages
簡介

ENT設備市場,預計在預測期間內以約6.4%的年複合成長率成長。耳朵、鼻子及喉嚨(ENT)用設備,是用於耳朵,鼻子或咽喉相關障礙的檢測,治療或手術的特別設備。還有指為了修復耳朵和鼻子和喉嚨的功能障礙所使用的合成材料和人工器官,改正聽覺,嗅覺,以及發音的問題。

本報告提供全球耳鼻喉科 (ENT) 用設備市場調查,整體市場趨勢,各產品、終端用戶、地區的詳細趨勢,市場成長的影響要素分析,競爭情形,主要企業簡介等資訊總括性彙整。

目錄

第1章 簡介

  • 市場定義

第2章 調查方法

第3章 摘要整理

第4章 主要影響要素

第5章 市場概要

  • 目前市場方案
  • 波特的五力分析
    • 供應商談判力
    • 消費者談判力
    • 新加入廠商的威脅
    • 替代產品與服務的威脅
    • 產業內的競爭

第6章 成長要素,阻礙因素,機會,課題分析(DROC)

  • 市場成長要素
    • 急速增加的高齡化人口
    • 定做植入物的增加趨勢
    • 技術進步
  • 市場阻礙因素
    • ENT設備的償付政策
    • ENT設備的高成本
  • 市場機會
  • 主要課題

第7章 市場區隔

  • 各產品
    • 診斷設備
    • 外科設備
    • 助聽器
    • 植入型助聽器
    • Co2雷射
    • 影像導引手術系統
  • 終端用戶
    • 家用
    • 醫院
    • 門診病人環境
    • 耳鼻咽喉診所
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第8章 競爭情形

  • M&A分析
  • 協定,合作,夥伴關係
  • 新產品的銷售

第9章 主要企業

  • American Hearing Systems Inc.
  • Audiosync Inc.
  • Beltone
  • Cochlear Ltd.
  • GN ReSound A/S
  • InHealth Technologies
  • Rexton Inc.
  • Siemens Healthcare, Panasonic Corp.
  • Sonic Innovations Inc.
  • Sonova Holding AG
  • Starkey Laboratories Inc.
  • Unitron Hearing Inc.
  • Zounds Inc.
  • 其他

第10章 市場未來展望

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 50024

The major factors for the growth of the ENT devices market include the increasing prevalence of ear, nose, and throat related disorders, rising adoption of minimally invasive ENT procedures, and technological advancements.

According to the estimates of 2018 by the World Health Organization, the prevalence of hearing loss has increased globally, even in developed countries. A per the report, in the United States, the incidence of hearing loss has increased from 11.5 million in 2008, to nearly 15 million in 2018.

Furthermore, according to the data published by the American Cancer Society, about 2,000 people in the United States develop cancers of the nasal cavity and paranasal sinuses each year. These cases are most common in the geriatric population. In 2018, in the United States, an estimated people were more than 15,000 incident cases of larynx cancer, as per International Agency for Research on Cancer 2018 data. Thus, owing to the rising prevalence and new cases of ear, nose, and throat related disorders, the US ENT devices market is expected to witness a high CAGR over the forecast period.

Key Market Trends

Hearing Aids is the Segment under Product Type is Expected to Account for Fastest Growth Rate during the Forecast Period

A hearing aid is a small electronic device that you wear in or behind your ear. It makes some sounds louder so that a person with hearing loss can listen, communicate, and participate more fully in daily activities. A hearing aid can help people hear more in both quiet and noisy situations. Hearing aids are primarily useful in improving the hearing and speech comprehension of people who have hearing loss that results from damage to the small sensory cells in the inner ear.

Moreover, the demand for these devices is increasing due to the increasing population with hearing loss. As per a 2018 report by the World Health Organization, the population with hearing loss is expected to increase from 466 million in 2018 to nearly 900 million by 2050. This will increase the demand for hearing aids, which will boost the market growth.

North America accounted for the Largest Share in the Global Market

North America is found to hold a major share for the ENT devices market and is expected to show a similar trend over the forecast period, without significant fluctuations. Most of the market players are based in North America and there is awareness about the advantages of using ENT devices solutions.

According to the estimates of the Hearing Health Foundation, there are 600,000-750,000 cases of Meniere's disease in the United States, with 45,000 to 60,000 new cases diagnosed annually. Favourable reimbursement policies, better healthcare infrastructure, high cases of chronic sinusitis, and other ENT disorders are the reasons for the high market share of the United States.

Competitive Landscape

The market studied is consolidated owing to the presence of a few major players in the market. The market players are focusing on R&D to develop the technologically advanced products in order to bring innovative products in the market. The barriers for the new entrants are high in this industry and hence only a few major market players hold the maximum market share.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Ear, Nose, and Throat Related Disorders
    • 4.2.2 Rising Adoption of Minimally Invasive ENT Procedures
    • 4.2.3 Technological Advancements
  • 4.3 Market Restraints
    • 4.3.1 High Procedure and Instruments Cost
    • 4.3.2 Social Stigma
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Diagnostic Devices
    • 5.1.2 Surgical Devices
    • 5.1.3 Hearing Aids
    • 5.1.4 Image-guided Surgery Systems
    • 5.1.5 Other Products
  • 5.2 By End User
    • 5.2.1 Hospitals
    • 5.2.2 ENT Clinics
    • 5.2.3 Other End Users
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East & Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East & Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 American Hearing Systems Inc.
    • 6.1.2 Atos Medical
    • 6.1.3 Cochlear Ltd
    • 6.1.4 InHealth Technologies
    • 6.1.5 Medtronic PLC
    • 6.1.6 Olympus Corporation
    • 6.1.7 Sivantos Group
    • 6.1.8 Starkey Laboratories Inc.
    • 6.1.9 Stryker Corporation
    • 6.1.10 Welch Allyn

7 MARKET OPPORTUNITIES AND FUTURE TRENDS